🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. sulfisoxazole diolamine

    SULFISOXAZOLE DIOLAMINE

    OPHTHALMIC FDA: approved

  2. sulfoxone sodium

    DIASONE SODIUM

    ORAL FDA: approved

  3. sulfur hexafluoride lipid-type a microspheres

    LUMASON

    INTRAVENOUS FDA: approved

  4. sulfur ointment (for use only as a base combined with active ingredients)

    NULL

    TGA: approved

  5. sulfur precipitated

    NULL

    TGA: approved

  6. sulphur hexafluoride

    SONOVUE

    EMA: approved

    V08DA05

  7. sumatriptan succinate

    SUMATRIPTAN SUCCINATE Tonix Pharmaceuticals Holding

    IONTOPHORESIS FDA: approved

  8. sunitinib malate

    SUTENT Teva Pharma GmbH

    ORAL FDA: approved

  9. susoctocog alfa

    OBIZUR

    EMA: approved

    B02

  10. sutimlimab-jome

    ENJAYMO

    INJECTION FDA: approved

  11. t-cell

    NMPA: clinical trials

  12. tacrine hydrochloride

    COGNEX

    ORAL FDA: approved

  13. tafamidis meglumine

    VYNDAQEL INITIAL APPROVAL

    ORAL FDA: approved · PMDA: approved

  14. tafasitamab-cxix

    MONJUVI

    INTRAVENOUS FDA: approved

  15. tafenoquine succinate

    KRINTAFEL

    ORAL FDA: approved

  16. tagraxofusp-erzs

    ELZONRIS

    INJECTION FDA: approved

  17. tak-

    NMPA: clinical trials

  18. talaporfin sodium

    LASERPHYRIN

    PMDA: approved

  19. talazoparib tosilate

    TALZENNA

    PMDA: approved

  20. talazoparib tosylate

    TALZENNA

    ORAL FDA: approved

  21. talc purified, sterilised

    NULL

    TGA: approved

  22. taletrectinib adipate

    IBTROZI

    ORAL FDA: approved

  23. taliglucerase alfa

    ELELYSO

    INTRAVENOUS FDA: approved · EMA: refused

    A16AB11

  24. talimogene laherparepvec

    IMLYGIC

    EMA: approved

    L01XX51

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources